Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy
about
Global transcriptome profiling identifies KLF15 and SLC25A10 as modifiers of adipocytes insulin sensitivity in obese womenMetabolite profiling in identifying metabolic biomarkers in older people with late-onset type 2 diabetes mellitus.Potentiation of Calcium Influx and Insulin Secretion in Pancreatic Beta Cell by the Specific TREK-1 Blocker Spadin.Integrated Strategies to Gain a Systems-Level View of Dynamic Signaling Networks.Glucagon and Insulin Cooperatively Stimulate Fibroblast Growth Factor 21 Gene Transcription by Increasing the Expression of Activating Transcription Factor 4.GLP-1 receptor regulates cell growth through regulating IDE expression level in Aβ1-42-treated PC12 cells.Sleeping Beauty Insertional Mutagenesis in Mice Identifies Drivers of Steatosis-Associated Hepatic Tumors.Loss-of-function variants in ADCY3 increase risk of obesity and type 2 diabetes.cAMP/PKA signaling pathway contributes to neuronal apoptosis via regulating IDE expression in a mixed model of type 2 diabetes and Alzheimer's disease.Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.Glucagon-Like Peptide-1 Receptor Agonist and Glucagon Increase Glucose-Stimulated Insulin Secretion in Beta Cells via Distinct Adenylyl Cyclases.Linderane Suppresses Hepatic Gluconeogenesis by Inhibiting the cAMP/PKA/CREB Pathway Through Indirect Activation of PDE 3 via ERK/STAT3.Er-Miao-Fang Extracts Inhibits Adipose Lipolysis and Reduces Hepatic Gluconeogenesis via Suppression of Inflammation
P2860
Q33751803-C6804085-481D-4CB9-8F6E-8BAB09330CA9Q33854354-25542F54-D4BA-413E-AEAD-4AE23D2EEC76Q37571762-FFD130DC-1AAC-41B7-AC69-40942942D144Q38881491-996950CC-7628-44E6-B509-C6FB1BE4E4E1Q45052537-C2960B76-9C6A-4214-9A91-4C03D2ED81D8Q47269433-A00223DE-A9B1-4AFC-91FD-29702BBBEC44Q47586118-7C890F42-AF6E-4CA3-980C-466E28A0DE56Q47745542-F1A3A5A2-B304-481A-A9DB-1383B394E8E9Q47945449-34BB75DB-E4B4-4429-BA55-0AE25ECA7C02Q51245495-46640708-5B6C-4CC5-9432-9C5F60332227Q53688080-AD8A7729-C889-4B41-AA63-A46EF978C5EAQ54977081-21FF7105-2F96-4857-8081-272CDA40F30CQ58781403-C839BF23-D8DE-47A6-94E1-C936A98094C1
P2860
Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy
@ast
Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy
@en
Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy
@nl
type
label
Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy
@ast
Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy
@en
Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy
@nl
prefLabel
Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy
@ast
Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy
@en
Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy
@nl
P356
P1476
Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy
@en
P2093
Haihua Yang
Linghai Yang
P304
P356
10.1530/JME-15-0316
P407
P577
2016-08-01T00:00:00Z